Assisting Manufacturers With 340B Refunds
When pharmaceutical manufacturers must restate or recalculate pricing, resulting in the need to issue refunds to covered entities, Apexus’ Manufacturer Refund Service can help.
Do you have a trusted solution for refunding overcharges? Apexus' Manufacturer Refund Service supports the Health Resources and Services Administration's (HRSA's) mandate for integrity and compliance in the marketplace, and helps mitigate risk and save time and money.
|Mitigate Risk||Save Time||Save Money|
|Timely refund of overcharges for 340B program integrity||Refunds processed within 90 days; enable your staff to focus on other priorities||Apexus' proprietary databases enable a lower cost solution|
|Apexus manages all the refund operations and processes||Correct refunds are issued as credits through the entity's pharmaceutical
distributor, or sent by check
|Apexus will provide all research required and full documentation|
How it works
What is The Manufacturer Refund Service?
Manufacturers sometimes need to provide refunds to 340B covered entities after restating their average manufacturer price (AMP) and/or Medicaid best price (BP), which results in a recalculation of the 340B ceiling price. In such situations, Apexus' Manufacturer Refund Service facilitates the processing of refunds as credits, directly to each covered entity's pharmacy distributor account.
Why Engage Apexus?
In support of initiatives for improving the integrity and compliance of the 340B program, Apexus offers the Manufacturer Refund Service, a fee-for-service program for pharmaceutical manufacturers who have identified the need to refund overcharges to eligible 340B entities. For manufacturers who may require assistance with 340B pricing restatements, Apexus has formed an alliance with Deloitte Risk and Financial Advisory. Deloitte can assist with the restatement process, and Apexus can assist with refunding covered entities through Manufacturer Refund Service.
Request more information: Manufacturer Refund Service program.